Similar organisations to HUDSON-ALPHA INSTITUTE FOR
-
Community Health Systems
-
2062.
Hackensack Meridian Health Inc
Keep getting better. Hackensack Meridian is a leading not-for-profit & the most comprehensive health care network in NJ.
109155
Neptune
-
Cancer Research
-
2063.
Iowa Oncology Research Association
TO BE ENGAGED IN THE PURSUIT OF BASIC AND CLINICAL ONCOLOGICAL RESEARCH, WHILE PROMOTING OPTIMAL AND COMPREHENSIVE CARE FOR THE ONCOLOGY PATIENTS IN IOWA.
Des Moines
-
Digestive Diseases/Disorders Research
-
2064.
Digestive Disease Research Foundation
CONDUCT AND SUPPORT CLINICAL MEDICAL RESEARCH IN THE FIELD OF GASTROENTEROLOGY.
New York City
-
Birth Defects, Genetic Diseases
-
2065.
Charlie Elenore Foundation
About Our Programs News Events Contact More.
San Diego
-
Private Grantmaking Foundations
-
2066.
Wallace Genetic Foundation II Inc
WALLACE GENETIC FOUNDATION HOME ABOUT US GRANT HISTORY HISTORY AND PHILOSOPHY In 1926 in Des Moines Iowa Henry A.
Washington
-
Employment Training
-
2067.
Inclusionbridge Inc
InclusionBridges mission is to diversify the data science workforce and build a future where everyone has access to the power of data.
Norwalk
-
Research Institutes and/or Public Policy Analysis
-
2068.
West Virginia Alliance for Creative Health Solutions Inc
The WVACHS is a practice-based research network leading patient-centered and community-oriented research to bring solutions to priority health disparities and health issues in the state.
Culloden
-
Professional Societies & Associations
-
2069.
BIOKATALYST A NEW JERSEY NONPROFIT CORPORATION
Home About Us Membership News Events Sponsorship Contact More BioKatalyst Inspire Biopharma Commercial Leadership One big Family BioKatalyst is a nonprofit professional organization of business leaders focused on the commercial areas of life sciences industry in the US and globally.
BELLE MEAD
-
Public Foundations
-
2070.
ISHLT FOUNDATION
The International Society for Heart and Lung Transplantation is a global, multi-disciplinary organization committed to improving care for patients with end-stage heart and lung disease.
676
CHICAGO

